NCT00369109View on ClinicalTrials.gov

Skin Biopsies and DNA Analysis in Patients Receiving Irinotecan or Gemcitabine For Advanced Solid Tumors

CompletedOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

February 28, 2006

Primary Completion Date

November 30, 2006

Study Completion Date

June 30, 2007

Conditions
Breast CancerColorectal CancerPancreatic Cancer
Interventions
OTHER

biologic sample preservation procedure

OTHER

immunohistochemistry staining method

OTHER

laboratory biomarker analysis

PROCEDURE

biopsy

Trial Locations (2)

48201-1379

Barbara Ann Karmanos Cancer Institute, Detroit

M20 4BX

Christie Hospital NHS Trust, Manchester

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Barbara Ann Karmanos Cancer Institute

OTHER

NCT00369109 - Skin Biopsies and DNA Analysis in Patients Receiving Irinotecan or Gemcitabine For Advanced Solid Tumors | Biotech Hunter | Biotech Hunter